Dr. Zewude[/caption]
Rahel Zewude, MD FRCPC
Infectious Diseases and Medical Microbiology, PGY-5
University of Toronto
MedicalResearch.com: What is the background for this study? Would you describe the syndrome of Auto-brewery syndrome?
Response: Auto-brewery syndrome refers to a syndrome where the gut ferments alcohol from carbohydrates leading to high blood alcohol levels and intoxication without any consumption of alcoholic drinks.
Dr. Targownik[/caption]
Laura Targownik, MD
Lead author and Clinician-Investigator
Mount Sinai Hospital in Toronto
Departmental Division Director, Gastroenterology and Hepatology
University of Toronto
MedicalResearch.com: What is the background for this study? Was there a difference in the types of patients or need for surgery seen by the female/male physicians?
Response: The background for this study is that there is an emerging body of literature that having a female physician leads to better patient outcomes in many health care settings, especially amongst patients undergoing surgery or being admitted to hospital. However, this has not previously been evaluated in gastroenterology. Female and male gastroenterologists may have different styles of practice on average, and this potentially could lead to differences in how patients engage with the health care system following an initial assessment.
Dr. Di Ciano[/caption]
Patricia Di Ciano, PhD
Scientist, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health
Assistant Professor, Department of Pharmacology and Toxicology
University of Toronto
Campbell Family Mental Health Research Institute
Collaborative Program in Neuroscience
MedicalResearch.com: What is the background for this study?
Response: It is now fairly well established that cannabis has a detrimental effect on driving. The most consistently reported effect of cannabis on driving is to increase ‘weaving’ on the road. We know that cannabis use is on the rise in people over 65 years of age. In fact, over the past few years cannabis use is increasing the most in this age group.
Despite this, there are few studies of the effects of cannabis on people over 65; most studies have been conducted on younger adults. We know that there are important age-related changes in the way the body works that may alter the impact of cannabis on the body. Also, older adults may have more experience with cannabis and this can change the effects of cannabis.
Dr. Kohan[/caption]
Andres Kohan MD
MHSc. in Translational Research
Joint Department of Medical Imaging
University Health Network
Mount Sinai Hospital and Women's College Hospital
University of Toronto
Toronto, Canada
MedicalResearch.com: What is the background for this study?
Response: Inequalities in access to healthcare for oncologic patients and its impact on quality of life and survival have been previously described. However, there also exists reports pointing out that when factors contributing to socioeconomic inequality are accounted for differences in outcome between races remain identifiable.
In this context, we sought to evaluate the presence of disparities in imaging in a selected population of patients with non-small cell lung cancer (NSCLC) within AACRs Project GENIE Biopharma Consortium (BPC) dataset v 1.1. This database is the largest in existence that has not only the patients’ imaging and clinical staging/follow-up, but also the genetic profile of the patients’ tumors.
Dr. Mahdavi[/caption]
Dr. Sara Mahdavi, PhD
Clinical Scientist and Clinical Instructor
Research Appointment in the Faculty of Medicine
University of Toronto
Toronto, ON
MedicalResearch.com: What is the background for this study?
Response: This was a long-term study spanning 16 years and began with a population of young adults who were medically assessed on a regular basis. It was remarkable to see just how striking the effects of coffee were in the group that had the susceptible genetic variant, what we termed “slow caffeine metabolizers” yet no effect whatsoever in those who did not were termed “fast metabolizers”.
Dr. Kirkham[/caption]
Dr. Amy Kirkham, PhD
Assistant Professor of Clinical Cardiovascular Health
Faculty of Kinesiology & Physical Education
University of Toronto
Affiliate Scientist at Toronto Rehabilitation Institute
MedicalResearch.com: What is the background for this study?
Response: Women who have had a breast cancer diagnosis are at least two-fold and often higher risk of cardiovascular or heart disease compared to women without a history of breast cancer. Older age, higher body mass index, and receipt of chemotherapy treatment that can injure the heart are risk factors for cardiovascular death after a breast cancer diagnosis.
Time-restricted eating is a type of intermittent fasting that appears to be easy to follow and to improve some measures of metabolic health but has not been studied in populations with a cancer history. Time-restricted eating simply involves consuming all calorie intake within a specific time window, commonly 8 hours, like between 12 and 8 pm, and then only consuming water or black coffee outside of those hours.
We enrolled breast cancer survivors who were aged 60 or older, had an overweight or obese mass index, and were finished chemotherapy treatment in a single-arm trial of time-restricted eating for 8 weeks. We asked participants to restrict their calorie intake between 12 and 8 pm from Monday to Friday with no restrictions on weekend and no further instructions on what to eat.
Peter Jüni, MD, FESC
Director, Applied Health Research Centre
Li Ka Shing Knowledge Institute of St Michael's Hospital
Department of Medicine
University of Toronto, Ontario
MedicalResearch.com: What is the background for this study?
Response: It is unclear whether seasonal changes, school closures or other public health interventions will result in a slowdown of the current coronavirus disease 2019 (COVID-19) pandemic. We studied 144 geopolitical areas around the world with more than 375,000 COVID-19 cases by March 27 to determine whether epidemic growth is globally associated with climate or public health interventions intended to reduce transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Dr. Watt[/caption]
Jennifer Watt, PhD
Clinical Epidemiology and Health Care Research
Institute of Health Policy, Management, and Evaluation
University of Toronto
MedicalResearch.com: What is the background for this study?
Response: Behavioral and psychological symptoms of dementia (e.g. aggression, agitation) are common among persons living with dementia.
Pharmacological (e.g. antipsychotics) and non-pharmacological (e.g. reminiscence therapy) interventions are often used to alleviate these symptoms. However, antipsychotics are associated with significant harm among older adults with dementia (e.g. death, stroke). Regulatory agencies such as the Food and Drug Administration (FDA) and Health Canada issued black box warnings to advise patients and clinicians of this potential for harm. And initiatives were championed to decrease the use of antipsychotics in persons living with dementia.
In response, we have seen a rise in the use of other pharmacological interventions, such as trazodone (an antidepressant). Its potential to cause harm in older adults with dementia is largely unknown.